Needle-free insulin soon in India
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
Tags: Biocon, biotechnology, Business Partnership, Business/Finance, Diabetes mellitus, Health/Medical/Pharmaceuticals, India, Inhalable insulin, inhaled insulin products, insulin, Insulin therapy, news, novo nordisk, Novo Nordisk A/S, oral, PFIZER INC., post manufacturing expenses, retail shops, Rs, Shreya Lifesciences, United States
NEWS REVIEW – BUSINESS
[This article was published in the November 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
Private Equity investments in pharma touch $400 m
Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine months of the year. This trend is set to accelerate as companies go for overseas acquisitions, hive off their R&D units, and Foreign Currency Convertible Bonds (FCCB) lose their sheen.
Ranbaxy to make China a major sourcing hub
Pharmaceuticals major Ranbaxy Laboratories plans to make China its major sourcing hub for active pharmaceutical ingredient (API).
SRIT forms a JV Company in Australia
Sobha Renaissance Information Technology (SRIT) have announced its Joint Venture (JV) with Capital Technic Group (CTG), an Australian Management Consulting & Services firm. The joint-venture capitalized at Australian $2.5m aims to produce $7.5m in annual revenues by the second year and ramping up to $65m by the fifth.
India, US to cooperate in developing medical technology
India and the United States have agreed to enhance cooperation in development of low-cost diagnostic and therapeutic medical technologies.
Veeda to adopt cancer hospitals for easy access to patient pool
A clinical research firm Veeda Clinical Research Pvt. Ltd is proposing a project, wherein it will adopt about a dozen cancer hospitals in tier-II and tier-III cities across India to ensure easy access to a wider patient pool for its drug test projects.
Hindujas plan to enter real estate, health care
The Hindujas Group currently holding a land bank of around 1,000 acre in the spread across India, plans to enter the country’s booming health-care sectors.
NEWS REVIEW – INDIA
[This article was published in the October 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News
Trivitron(Chennai, India) and Aloka(Japan) sign JV
Trivitron group of companies, the largest Indian medical technology company and Aloka, the innovators in Ultrasound technology from Japan today announced their joint venture agreement to manufacture cost effective, High Technology Ultrasound equipment in India to suit the needs of the developing countries. The Joint Venture will embark on an Initial investment of about 50 crores by both the companies followed by further investments in due course.
Trivitron and Aloka sign a JV to manufacture high Technology Ultrasound equipment in India
Trivitron group of companies, the largest Indian medical technology company and Aloka, the innovators in Ultrasound technology from Japan today announced their joint venture agreement to manufacture cost effective, High Technology Ultrasound equipment in India to suit the needs of the developing countries. The Joint Venture will embark on an Initial investment of about 50 crores by both the companies followed by further investments in due course.
NEWS REVIEW – INDIA UPDATE
[This article was published in the August 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News
